Department of Paediatric Dermatology, Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Australas J Dermatol. 2012 Aug;53(3):216-8. doi: 10.1111/j.1440-0960.2012.00901.x. Epub 2012 Jun 4.
The mechanism of action of beta adrenergic blockers in the involution of infantile haemangioma (IH) remains unclear. It has been proposed that the renin-angiotensin pathway may play a role. We present a retrospective case series of 17 patients with IH who were treated with oral corticosteroid therapy and developed hypertension requiring treatment with the angiotensin converting enzyme inhibitor, captopril. All patients, with written documentation, demonstrated an improvement in their lesion at the start of oral corticosteroid therapy (n = 14). Captopril alone did not sustain the corticosteroid-induced involution with a documented worsening of infantile haemangioma in seven out of 12 patients (58%).
β肾上腺素能阻滞剂在婴儿血管瘤(IH)消退中的作用机制尚不清楚。有人提出肾素-血管紧张素系统可能起作用。我们报告了 17 例接受口服皮质类固醇治疗并发生高血压需用血管紧张素转换酶抑制剂卡托普利治疗的 IH 患者的回顾性病例系列。所有患者(有书面记录)在开始口服皮质类固醇治疗时均显示病变改善(n=14)。卡托普利单独治疗不能维持皮质类固醇引起的消退,12 例中有 7 例(58%)婴儿血管瘤有记录的恶化。